In our inaugural episode of Eight Drugs a Week we are very lucky to be joined by two former IATDMCT Presidents, Loralie Langman and Pierre Marquet. Both are very well known for their work with immunosuppressant drugs, particularly in the context of transplantation.

In this episode we talk about:

Planning the ideal immunosuppressant monitoring program in solid organ transplant recipients

Why France is ahead of the curve in immunosuppressant TDM

Why a particular mycophenolate TDM RCT is the ‘poster study’ for TCI in the TCI vs TDM debate

Lessons learned in microsampling using DBS and VAMs for immunosuppressant monitoring

Eight Drugs a Week is supported by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT). The personal views of the hosts and guests do not necessarily reflect the position of the Association.

To join IATDMCT, visit https://www.iatdmct.org/member-join

Subscribe to Eight Drugs a Week on your preferred podcast platform.

About our guests:

Loralie Langman is one of the Directors of the Clinical and Forensic Toxicology Laboratory at the Mayo Clinic, Rochester, Minnesota, as well as a Consultant for the Personalized Genomics Laboratory. She is Professor of Laboratory Medicine and Pathology at the Mayo Clinic College of Medicine.

Pierre Marquet is Professor of Pharmacology at the Medical School, University of Limoges, France. He heads the pharmacology-toxicology department at Limoges University Hospital and is director of the research unit “Pharmacology and Transplantation”.